Introduction
It is well recognised that the clinical and pathological diagnosis of pigmented lesions can be extremely difficult. Misdiagnosis of melanoma can have tragic results for individuals, and overdiagnosis can result in excessive direct and indirect health-care costs. 1, 2 In recent years, evidence has accumulated that dermoscopy, confocal microscopy and other techniques can improve the accuracy of the clinical diagnosis of pigmented lesions and facilitate the recognition of melanomas at an earlier (and potentially curable) clinical stage. 3, 4 Dermoscopy utilises a magnifier and cancels skin surface reflections with either polarised light or a liquid medium, enabling better recognition of lesional characteristics. Reflectance confocal microscopy provides resolution at a cellular level down to the papillary dermis, allowing instant visualisation of skin structures. 5, 6 However, the use of such techniques have, in turn, presented additional challenges to pathologists, particularly in identifying and diagnosing early melanomas arising focally in association with a benign pigmented lesion.
When a focal area of clinical concern is identified within a pigmented lesion it is critical that this area, even if very small, is examined histologically because it may represent a melanoma arising within a benign lesion. If it is not melanoma, a search for histopathological features that might correlate with the clinical appearances must be sought. Clinical or other diagnostic photographic images or a diagram are sometimes included with the pathology request form to direct the pathologist to any area of particular clinical concern in the specimen and to improve clinicopathological correlation. However, after tissue fixation the clinical appearance of the lesion is often distorted, leading to doubt as to the location of the atypical focus and ultimately concern that a small focus of melanoma may not have been recognised.
In recent years we have utilised a modified version of a 'punch scoring' technique to mark the site of any atypical focus within a pigmented lesion to provide certainty of adequate histopathological examination. This technique was first described by Braun et al. in 2003 , with a single case example using a 1-mm punch biopsy circular blade that was inserted partially into the skin to mark or 'score' the area of interest. 7 In this study, we sought to evaluate the accuracy of 'scoring' the skin surface superficially, using a punch biopsy, to highlight any clinically or dermatoscopically identified focus of clinical concern within excised pigmented lesions, to identify earlystage melanoma and improve clinicopathological correlation.
Methods
A retrospective analysis was performed of a prospectively collected cross-sectional series of pigmented skin lesions in which a focal area of clinical and/or dermoscopic concern for possible melanoma within the lesion was 'scored' superficially utilising a punch biopsy. Specimens were identified by searching the electronic pathology database of the Department of Tissue Pathology and Diagnostic Oncology at the Royal Prince Alfred Hospital (RPAH), Sydney, Australia for cases accessioned between July 2009 and August 2012 using the search terms 'Skin + Score' and 'Skin Score'. A total of 45 cases were found; however, pathology slides were available for review in only 43 cases, and a further two cases were excluded after histopathological review due to the absence of a microscopically identifiable score. The remaining 41 specimens (from 40 patients) were analysed further.
In our study, scoring involved enclosing the suspicious area within the diameter of the punch biopsy, which was not limited in size, and inserting the punch biopsy into the epidermis and superficial portion of the dermis. The punch biopsy was then extracted without causing tissue disruption. The specimens were fixed in formalin. The scored region was submitted selectively, usually in a separate tissue block, and examined at multiple levels.
For each case, the age, sex, anatomical site and clinical diagnosis were recorded. The size and macroscopic appearance (including the degree of pigmentation, pigment variegation and distance to the superficial margins) of the whole lesion were also recorded; in cases where variation between the scored region and remaining lesion could be identified ex vivo, these features were noted similarly.
The lesion was submitted entirely in each case, with two levels ordered routinely on the block containing the 'score'. In many cases, additional levels were cut into the block of tissue containing the 'scored' focus. The lesion outside the scored focus was processed as per the routine protocol for examination of melanocytic lesions in our laboratory (macroscopically cut into pieces less than 4 mm in thickness, all the lesion embedded, and single sections stained with haematoxylin and eosin (H&E); deeper levels were cut and examined if considered pertinent by the reporting pathologist). The standard depth between levels at our laboratory is 50 lm.
Retrospective review of all the cases by at least two pathologists (J.G., C.L.C. and/or R.A.S.) was conducted and features including the presence of the score and histopathological correlates were assessed and compared to the original findings. Regression was defined by the presence of a constellation of histological features including tumour-infiltrating lymphocytes, fibrosis, angioplasia (increased numbers of small blood vessels) and melanophages. 8 Irritation was defined as suprabasal spread of melanocytes without atypia in the context of parakeratosis and epidermal thickening. 9, 10 This study fell under the authority of ethics protocols no. X11-0023 and HREC/11/RPAH/32 approved by the Ethics Review Committee, RPAH zone on 24 February 2011 and research was conducted according to the principles of the Declaration of Helsinki. Informed written consent was not required for this study.
Results
The clinical and pathological features of the cases are summarised in Table 1 . The scored region was submitted whole in a separate tissue block in 19 of 41 specimens, bisected in 21 of 41 specimens and trisected in one specimen. Irrespective of the treatment of the score at macroscopic cut-up (whether the 'score' was separately submitted, bisected/trisected or inked), the score was visualised clearly in the vertical plane as two parallel incisions in the epidermis and superficial dermis. An estimation of the punch biopsy size was made by measuring the maximum width of the score seen on H&E sections (range: 1-8 mm, median: 1.5 mm).
The proportion of each lesion contained within the circumference of the score (score/lesion size ratio) was made at the time of microscopic review of all sections, and ranged between 5% and 100% (mean: 23, median: 20). The single case in which the entire microscopic lesion appeared contained within the score had demonstrated a more extensive macroscopic appearance, which did not show a clear histopathological correlate beyond the scored focus. Only five specimens showed no specific features within the scored region; four of these underwent deeper levels (range: 2-5).
The total number of additional levels cut into the paraffin block of tissue that included the scored focus ranged from 1 to 15 (mean: 4, median: 3.5). The deepest levelling was required for further interpretation of a combined benign dysplastic naevus and blue naevus. There was no correlation between the punch biopsy size and the number of levels examined.
The pathological features and diagnoses of the lesions are summarised in Table 2 . Melanoma was diagnosed in nine of 41 specimens: six cases of melanoma in situ without invasion and three cases of invasive melanoma. An associated naevus was identified in eight of nine melanoma cases (combined lesions). In seven of eight of these cases, the melanoma was identified preferentially within the scored region, even when the scored focus corresponded to a small proportion of the entire combined lesion (range: 5-50%, mean: 24%, median: 25%).
The two melanomas within the scored region had Breslow thicknesses of 0.8 and 1.18 mm, respectively. The invasive component was contained entirely within the score in both cases. In the third case, a focal area of invasive melanoma (Breslow 0.25 mm) was present outside (but not within) the scored area. All three invasive tumours were nonulcerated and had mitotic rates of 0/mm 2 . None of these three patients underwent sentinel node biopsy.
Overall, including combined lesions and isolated melanomas, the score encompassed the melanoma entirely in six of nine cases, and included at least a portion of the melanoma in seven of nine cases (Figures 1 and 2 ). Additionally, in one case of early melanoma in situ, the diagnostic material was identified only on further levelling through the scored focus. These data suggest that the scored regions showed a high positive correlation with the site of melanoma, whether present as part of a combined lesion or in isolation.
In one case of in-situ melanoma without an associated naevus, the score contained only 40% of the melanoma and the most florid diagnostic features were identified outside the scored region. However, the score identified an area with histopathological features suspicious for the presence of regressed melanoma. Of the two of nine melanoma cases that were identified exclusively outside the scored focus, one case showed regression within the scored area but lacked residual melanoma and the other showed only a region of basal hyperpigmentation, yet the score contained only 5% of the entire lesion. In these cases, the score may have failed to encompass the relevant portion of the lesion due to either small score diameter relative to lesional size or due to the presence of regression, which is in and of itself an important feature of melanoma and may account for areas of clinical variance across the lesion.
In the majority of specimens (36 of 41), the clinical impression correlated with the presence of isolated or combined specific histopathological features (such as dermal melanophages 12 of 41, regression nine of 41, irritation two of 41 and/or variation in pigment distribution seven of 41) or by a diagnostic entity (such as melanoma, blue naevus, deep penetrating naevus, haemangioma, seborrheic keratosis or dysplastic naevus features) (Figures 3 and 4) . The best diagnostic features of these lesions were identified within the scored foci in 22 of 32 exclusively benign specimens. 
Discussion
Clinical examination of pigmented lesions is performed in the plane parallel to the skin surface, allowing complete visualisation of the whole lesion for suspicious features. 11, 12 Diagnostic aids, such as reflectance confocal microscopy, dermoscopy and digital dermoscopy, have improved clinicopathological correlation and facilitated the clinical recognition of very early stages of melanoma. [12] [13] [14] [15] Despite improvements in the accuracy of clinical diagnosis, differentiation between benign and malignant lesions often remains difficult, with confounding factors well recognised. 12, [16] [17] [18] Histopathological diagnosis of pigmented skin lesions is considered widely to be the gold standard, 19 and this is achieved by assessing architectural and cytological features as well as the host response. 20 A credible diagnosis also requires correlation with clinical data, including the clinical appearance of the lesion, anatomical site and the sex and age of the patient, as well as an awareness of potential pitfalls. 21 The distinction between benign and malignant melanocytic tumours can be particularly difficult in partial biopsy specimens, and multiple studies have demonstrated an increased risk of misdiagnosis of melanoma. 22, 23 It is therefore usually recommended that an excision biopsy with narrow margins be performed (unless there are clinical reasons why this is inadvisable). 24, 25 Discordance between the clinical and histological diagnoses may occur if the lesion is sampled inadequately for pathological examination. 26, 27 While it is generally recommended that the entire lesion be embedded for microscopic examination of clinically suspicious pigmented lesions, 28 there is no consensus on the method of selection of tissue blocks or the number of deeper levels that should be obtained from each slice, either between individuals or institutions. 29 The lesion is usually sliced into multiple pieces, each being up to 4 mm in thickness (which corresponds to the depth of a tissue cassette). However, the region of clinical concern, especially if it is focally present within a pre-existing lesion, may be less than a millimetre in diameter. Accordingly, the intermittent vertical sections (or 'levels') which are cut from each slice and reviewed by the pathologist may not demonstrate the focus of clinical suspicion unless every slice of the lesion is embedded in a block and each tissue block is thoroughly 'levelled', which in most laboratories is not a standard practice due to time and economic constraints. 30, 31 As described above, inaccurate diagnoses or clinicopathological discrepancies may occur as a consequence of under sampling in the pathology laboratory. 32 In some instances where there is a discrepancy between the clinical and pathological diagnosis, it is important that there is discussion with the pathologist to determine the cause of any discrepancy, and that additional deeper levels of the specimen be examined histologically. 33 Deeper 'levelling' of the tissue block may not only alter the diagnosis, but may also change staging and prognostic parameters. 31 These initially unrecognised errors result occasionally in litigation. The potential for melanoma to develop within a pre-existing naevus contributes to this dilemma. 30, 35, 36 Up to 30% of melanomas will arise within a pre-existing naevus, and there is a recognised trend for melanoma to be under-diagnosed in this circumstance. 30, 35, 36 If the clinical indication of the suspicion of malignancy is not conveyed to the pathologist, there is a risk that further sectioning may not be pursued after the naevus is recognised due to reduced impetus to continue searching after a benign diagnosis is identified. Conversely, if the clinical suspicion is clearly indicated but without visual correlation of the site within the lesion, the exhaustive sectioning required to identify the presence of melanoma may not be undertaken.
This issue has prompted multiple investigators to improve upon current methods of clinicopathological correlation, including dermoscopic photographs and diagrams with areas of suspicion marked for sampling, ex-vivo dermoscopic examination and physical markers to indicate sites of interest, including sutures and ink. 11, 26, 30, [36] [37] [38] [39] These techniques are time-consuming and may require special expertise not available to a general pathology laboratory; accordingly, some, such as ex-vivo dermoscopy, have not been introduced widely into the current practice of many laboratories, particularly in a community setting.
This study shows the practical utility of a simpler technique, namely punch scoring, which is applicable to general pathology laboratories and does not require special expertise in dermoscopy or clinical attendance by the pathologist and interpretation during sectioning of the macroscopic specimen. Focusing the pathologist to the site of interest increases sampling of appropriate regions of the specimen and alerts the pathologist to the potential for malignant but potentially missed diagnoses. 30 This technique was apparently first described by Braun et al. and later by Pellacani et al., who used a 2-mm punch biopsy score. 7, 40 We recommend that pathologists routinely examine sections taken at two different levels from the block containing the scored focus. Additional sections should be examined if there are ambiguous findings with resulting diagnostic uncertainty, or if the pathological findings do not explain the clinical appearance within the scored focus.
Our study concentrated on identifying the pathological correlate of suspicious clinical findings that would trigger the excision of a melanocytic lesion, such as atypia, dual pathology or change. In the cases diagnosed as melanoma, irrespective of the suspected clinical diagnosis, in the majority of cases the region scored identified the most relevant pathology. In our institution, the use of the punch biopsy score allowed further levels/sections of the clinically indicated focus to be examined selectively. This is cited to improve the pathologists' (and also the clinicians') confidence that the suspicious focus has been examined adequately without the need for exhaustive sectioning of the entire specimen. Furthermore, from a clinical perspective, it provided feedback on the accuracy of visual or dermoscopic features and the direct pathological correlate. 32, 41 In 36 of our 41 cases, the features detected clinically could be explained by pathological changes identified within the scored region, and in only five of 41 cases were there no specific histopathological features identified within the boundaries of the score that could explain the clinically highlighted area of concern. Our study supports the contention that utilisation of a punch biopsy alone may miss cases of melanoma arising within pigmented lesions, as two of nine cases had melanoma exclusively outside the scored areas. Marking the site of particular concern in an excision biopsy of a pigmented lesion is especially important in cases that may represent a melanoma arising in association with a naevus. The technique described herein provides a means of improving communication between pathologists and clinicians to ensure that suspicious lesions are sampled adequately, and highlights focal atypia to prevent features being missed during routine sectioning. It is also readily applicable to laboratories without special clinical expertise or experience in dermatopathology, and provides a direct visual correlation with the clinically observed regions prompting excision, permitting greater certainty in the pathological diagnosis. 
